Codagenix, Serum Institute of India start first-in-human trial of Covid-19 vaccine
Codagenix, Inc., and the Serum Institute of India Pvt. Ltd. (SIIPL) have announced that a Phase 1 clinical trial of COVI-VAC received regulatory approval...
SK Biopharmaceuticals, LifeSci Venture Partners announce partnership for Open Innovation
Innovative pharma company SK Biopharmaceuticals, Co., Ltd., has inked a pact with global life science venture capital firm LifeSci Venture Partners to collaborate on...
NeuroRx starts Phase 2/3 study of inhaled ZYESAMI
NeuroRx, Inc. has announced initiation of a Phase 2/3 clinical trial investigating the role of inhaled ZYESAMI (aviptadil).
The trial is being done for the...
Aspirin being tested as possible treatment for Covid-19
The humble Aspirin is all set to take on the mighty Covid-19. For, the commonly used medicine is being investigated in the world’s largest...
NIH starts study of Covid infection and multisystem inflammatory syndrome
NIH has started an observational study has launched to evaluate the short- and long-term health outcomes of SARS-CoV-2 infection in children
This includes multisystem inflammatory...
Management of long-term effects of Covid-19 ; revelations of NICE & medial bodies
NICE, SIGN and RCGP have set out more details about the United Kingdom guideline on management of the long-term effects of Covid-19 pandemic.
The guideline...
Lupus Research Awards 2023 announced
The Lupus Research Alliance (LRA) announced the recipients of the newest Lupus Innovation Award (LIA) grants.
Collectively, the seven projects led by research teams from the U.S. and Europe explore multiple...
Haoma Medica’s novel treatment for osteoporosis, NaQuinate, undergoes first human trial
Haoma Medica has announced the completion of a first-in-human trial for NaQuinate. A naphthoquinone carboxylic acid, it is being developed as a novel orally...
Coronaviruses hijack the cell’s trash disposal system to spread through the body
With Covid-19 cases increasing across the world, researchers are working to better understand how the virus that causes the disease infects cells and spreads...
Moderna to supply additional 2 mn doses of Covid-19 vaccine to United Kingdom
Moderna, Inc. has announced a supply agreement with the United Kingdom government for an additional 2 million doses of mRNA-1273,
Moderna is a biotechnology company...
